Yesterday | US News & World Report
Should the Birth Control Patch Be Pulled?
News is looking worse and worse for the contraceptive patch made by Ortho Evra . via US News & World Report
Comment?
Birth Control Forum & PollsWednesday May 14 | EMaxHealth
Birth Control Patches Pose Health Risk
A US consumer advocacy group is asking FDA to pull off Johnson & Johnson's birth control patches Ortho-Evra, because they pose health risk. via EMaxHealth
Monday May 12 | Medical News Today
Public Citizen Calls On FDA To Withdraw Ortho Evra Patch From Market Over Safety Concerns
“Hormonal birth control methods have benefits and risks. The approved labeling has always stated the known risks associated with its use.”
Main Category: Women's Health / Gynecology Also Included In: Sexual Health / STDs ; Regulatory Affairs / Drug Approvals Article Date: 12 May 2008 - 0:00 PDT Public Citizen 's Health Research Group on Thursday ... via Medical News Today
Saturday May 10 | MySanAntonio.com
New company to develop drugs for women
“We're not talking about 10 years. We're not talking about five years.”
The Southwest Foundation for Biomedical Research is taking a step toward putting San Antonio on the biomedical industry map by spinning off a company focused on women's health drugs. via MySanAntonio.com
Thursday May 8 | Denver Post
Group asks government to end use of birth-control patch
“The approved labeling has always stated the known risks associated with its use.”
A consumer advocacy group petitioned the government Thursday to pull the birth-control patch off the market, calling it far riskier than the pill. via Denver Post
Tuesday May 6 | The Daily Bruin
“We basically try to accommodate both (students') medical and contraceptive needs and their financial needs”
Due to legislative error, birth control co-pays are greater on college campuses since 2007 Protection from unwanted pregnancies is becoming more expensive and daunting for more than three million college-age ... via The Daily Bruin
Thursday May 1 | Nursing Center
DRUG Watch Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. via Nursing Center
Tuesday Apr 29 | Columbia Spectator
Health Services Announces Plan to Lower Cost of Student Birth Control
“We have seized this opportunity and expanded the benefit to make generic prescriptions more affordable for every student who needs them”
Following pressure from student groups, Health Services at Columbia announced Tuesday that it would reduce the cost of the NuvaRing and other birth control methods for students. via Columbia Spectator
Sunday Apr 27 | Bloomberg.com
AstraZeneca, Bristol-Myers, Bayer Earnings Drop on Costs, Generic Rivals
AstraZeneca Plc , the U.K.'s second- largest drugmaker, U.S. rival Bristol-Myers Squibb Co. via Bloomberg.com
Friday Apr 25 | Women's eNews
Chile Birth-Control Case Spurs 'Apostasy' Planning
“This ruling represents a huge step backwards in terms of equal (access to the pill)”
Hundreds of Chileans are planning to renounce their membership in the Roman Catholic Church on April 29 as an outcry against a major blow to the government's push for expanded access to contraception. via Women's eNews
Birth Control Editors
I edit this news page on Topix when no humans are available to help.
One big 
News Trends
Topix Quick Polls
